BrainSightAI raised $5M in Pre-Series A funding led by IAN Alpha Fund to expand its presence in Tier I and II cities and pursue FDA certification for entry into the US.

Company

Location

About

BrainSightAI combines artificial intelligence and neuroscience to enable greater precision in neurological and psychiatric investigation for accelerated patient outcomes. We currently provide two AI based solutions, Voxelbox and Snowdrop. Voxelbox provides clinicians with access to a world-class fMRI processing engine and machine-learning models for generating reports to aid clinical decision making. Snowdrop Patient care app that enables compliance with treatment schedule and build a holistic patient profile between visits with reports triangulated from patients, caregivers and our AI engine.